Wells Fargo’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-447
Closed -$186 7075
2025
Q2
$186 Sell
447
-16,014
-97% -$8.08K ﹤0.01% 6445
2025
Q1
$10.3K Buy
16,461
+362
+2% +$435 ﹤0.01% 5878
2024
Q4
$26.9K Buy
16,099
+5,603
+53% +$8.61K ﹤0.01% 5683
2024
Q3
$19.1K Sell
10,496
-79
-0.7% -$294 ﹤0.01% 5653
2024
Q2
$63.8K Buy
10,575
+1,251
+13% +$15.4K ﹤0.01% 5195
2024
Q1
$104K Buy
9,324
+1,028
+12% +$14.4K ﹤0.01% 4874
2023
Q4
$124K Buy
8,296
+2,890
+53% +$27.4K ﹤0.01% 4775
2023
Q3
$25.9K Sell
5,406
-3,627
-40% -$19.7K ﹤0.01% 5493
2023
Q2
$67.8K Buy
9,033
+3,928
+77% +$25.7K ﹤0.01% 5259
2023
Q1
$23.1K Buy
5,105
+3,313
+185% +$25.1K ﹤0.01% 5578
2022
Q4
$20.2K Buy
1,792
+946
+112% +$10.6K ﹤0.01% 5257
2022
Q3
$9K Sell
846
-2,718
-76% -$31.7K ﹤0.01% 5710
2022
Q2
$29K Sell
3,564
-6,889
-66% -$75K ﹤0.01% 5272
2022
Q1
$177K Sell
10,453
-4,079
-28% -$69.6K ﹤0.01% 5048
2021
Q4
$312K Buy
14,532
+8,062
+125% +$348K ﹤0.01% 5015
2021
Q3
$478K Buy
6,470
+5,543
+598% +$369K ﹤0.01% 4684
2021
Q2
$50K Buy
927
+20
+2% +$1.2K ﹤0.01% 5553
2021
Q1
$67K Sell
907
-12,556
-93% -$988K ﹤0.01% 5666
2020
Q4
$1.16M Buy
13,463
+6,205
+85% +$373K ﹤0.01% 3919
2020
Q3
$274K Buy
+7,258
New +$285K ﹤0.01% 4775

Other funds holding ALXO